Pacific Point Advisors LLC Buys 1,187 Shares of UnitedHealth Group Incorporated $UNH

Pacific Point Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 30.0% in the second quarter, Holdings Channel.com reports. The firm owned 5,145 shares of the healthcare conglomerate’s stock after buying an additional 1,187 shares during the period. UnitedHealth Group comprises about 0.9% of Pacific Point Advisors LLC’s holdings, making the stock its 27th biggest position. Pacific Point Advisors LLC’s holdings in UnitedHealth Group were worth $1,605,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. Brighton Jones LLC boosted its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. Milestone Asset Management LLC increased its stake in UnitedHealth Group by 3.6% in the first quarter. Milestone Asset Management LLC now owns 692 shares of the healthcare conglomerate’s stock worth $363,000 after purchasing an additional 24 shares during the period. Baxter Bros Inc. boosted its stake in shares of UnitedHealth Group by 30.3% during the first quarter. Baxter Bros Inc. now owns 860 shares of the healthcare conglomerate’s stock valued at $450,000 after purchasing an additional 200 shares during the period. Finally, Merit Financial Group LLC increased its stake in UnitedHealth Group by 39.1% in the 1st quarter. Merit Financial Group LLC now owns 20,573 shares of the healthcare conglomerate’s stock worth $10,775,000 after buying an additional 5,784 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on UNH. JPMorgan Chase & Co. dropped their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Barclays raised their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $358.95.

UnitedHealth Group Trading Down 0.0%

NYSE UNH opened at $345.11 on Wednesday. The firm has a market cap of $312.56 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 2.25 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a 50 day moving average price of $303.65 and a 200 day moving average price of $357.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.